Essex Angel Capital Inc.
TSX VENTURE : EXC

Essex Angel Capital Inc.

February 03, 2012 15:59 ET

Essex Angel Capital Inc. Announces: Wellness Indicators, Inc. Founder Is Guest Speaker at National Labor Management Conference

WINDSOR, ONTARIO--(Marketwire - Feb. 3, 2012) - Essex Angel Capital Inc. (TSX VENTURE:EXC) (the "Corporation" or "Essex") is pleased to announce that Denis Callewaert, Founder and Chief Science Officer of Wellness Indicators, Inc. ("Wellness Indicators"), one of the companies in the Essex portfolio, will be a guest speaker at the National Labor Management Conference in Hollywood, FL, February 16-21, 2012. Dr. Callewaert, who holds a Ph.D. in biochemistry, will be addressing the attendees about the unique aspects of Wellness Indicators' new wellness screening test, the Health Equater™ Assessment Profile.

One thousand attendees at the National Labor Management Conference will be offered the opportunity to participate in field trials of the Health Equater Assessment Profile, which is a quick and inexpensive urine test that screens for biomarkers indicating levels of wellness. The National Labor Management Conference is only one of the sites where the Health Equater Assessment Profile will be field-tested. Further field trials during the first quarter of 2012 will take place at a number of large insurance companies, large employers and organized labor unions. Wellness Indicators has field trial commitment letters from eight organizations, representing over 1,000,000 potential users, of whom 2,000 will be participating in field trials in the first quarter of 2012.

"Wellness Indicators is a game-changer in the Labor space," said Ed Hanley, former Chief Legal Counsel of Hotel Employees and Restaurant Employees and Bartenders International Union and current CEO of A&E Group Health Solutions LLC, "which brings a non-invasive, portable, affordable method for funds and their members to manage their own personal health. I am excited to share this new solution next week at the National Labor Conference, where some 1,000 different funds will be represented."

An international expert in biochemistry and immunology, with a focus on biomarkers for oxidative stress and inflammation, Dr. Callewaert has founded four biotechnology companies, including Wellness Indicators. The company plans to introduce the Health Equater Assessment Profile commercially, after field tests are completed.

The Health Equater Assessment Profile is a first-to-market test screening for such biomarkers as oxidative stress, low-grade inflammation and total antioxidant capacity, which indicate levels of wellness. Thousands of studies have shown that the biomarkers detected by the assessment profile are leading indicators for a variety of future health risks, including stroke, cancer, heart disease, and diabetes. The value of the Health Equater Assessment Profile is that it is non-invasive, results are ready in five minutes and it gives an indication at the individual level of how a person is functioning metabolically before the onset of chronic disease, when intervention is less expensive and more effective. Results are available in approximately five minutes, instead of the week that traditional lab tests require. Other advantages include ease of use, portability, and low cost, being approximately $30 per test, rather than around $100 for most current diagnostic tests.

"The field trials at the National Labor Management Conference, is a significant step forward for Wellness Indicators," said Rick Galdi, President and CEO of Essex. "The invitation for Dr. Callewaert to speak on the subject and the immediate availability to participate in the trial lays a strong foundation for future test sales."

This press release contains certain forward-looking statements about the future plans and intentions of companies in the Corporation's portfolio. Wherever possible, words such as "may," "will," "should," "could," "expect," "plan," "intend," "anticipate," "believe," "estimate," "predict," or "potential," or the negative or other variations of these words, or similar words or phrases, have been used to identify these forward-looking statements. These statements reflect Management's current beliefs and are based on information currently available to Management as at the date hereof. Forward-looking statements included or incorporated by reference in this press release include statements with respect to completion of Wellness Indicators' field trials in the first quarter of 2012, successful commercial launch of the Health Equator Assessment Profile later this year and the future business activity of Wellness Indicators.

Forward-looking statements involve significant risk, uncertainties, and assumptions. Many factors could cause actual results, performance, or achievements to differ materially from the results discussed or implied in the forward-looking statements. These factors should be considered carefully and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this press release are based upon what management believes to be reasonable assumptions, the Corporation cannot assure readers that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this press release, and the Corporation assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law.

Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release.

Contact Information